As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...

These drugs belong to a class known as glucagon-like peptide receptor agonists (GLP-1RAs), which mimic a natural hormone that ...

Dealmaking in the Asia Pacific (APAC) region took off this week, with the latest showcasing Genome & Co.’s licensing deal ...